aid: antengene
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/antengene.png
name: antengene
description: Antengene Corporation is a commercial-stage, R&D-driven global biopharmaceutical company
  focused on discovering, developing, and commercializing first-in-class and best-in-class therapies
  for the treatment of hematologic malignancies and solid tumors. Headquartered in Shanghai with a
  global footprint across the Asia Pacific region and beyond, Antengene's marketed product XPOVIO
  (selinexor) and a pipeline of oncology assets such as the Claudin 18.2 antibody-drug conjugate
  ATG-022 and the CD73 inhibitor ATG-037 target unmet needs in cancer care. Antengene operates in the
  life sciences sector and does not currently publish a public developer API, SDK, or developer portal;
  this profile was surfaced as a portfolio company of Qiming Venture Partners and captured in the API
  Evangelist network for company intelligence and enrichment.
url: https://raw.githubusercontent.com/api-evangelist/antengene/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
humanURL: https://antengene.com
tags:
- Company
- Biopharmaceutical
- Oncology
- Pharmaceuticals
- Healthcare
- Life Sciences
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/antengene-domain-security.yml
- type: Website
  url: https://antengene.com
- type: PrivacyPolicy
  url: https://antengene.com/about.html
- type: TermsOfService
  url: https://antengene.com/about.html
- type: Blog
  name: Newsroom
  url: https://antengene.com/news.html
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence